Preparing for Your Targeted Treatment in the Clinic

Read article

Preparing for Your Targeted Treatment in the Clinic

For the VP of Clinical Operations (or a…
Read Article

ASCO 2024 – Takeaways from Five Key Studies

If you didn’t get to attend the 2024…
Read Article

Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024

The 2024 ASCO Annual Meeting presents an unmissable…
Read Article

Embracing AI in Clinical Trials: An Oncology CRO’s Insight

In our previous article, we outlined how AI…
Read Article

Transforming Oncology Drug Development with Artificial Intelligence

The release of GPT 3.5 and the improvement…
Read Article

FDA’s New Guidance on Diversity in Clinical Trials: New Challenges for Patient Recruitment

The U.S. Food and Drug Administration (FDA) recently…
Read Article

The Poster Child of International Clinical Trial Success: Legend Biotech’s Carvykti/Cilta-cel Immunotherapy Achieves FDA Approval

With many in biotech and pharma in China…
Read Article

Chinese Clinical Trial Data – Still Relevant to the FDA

For Chinese companies bringing oncology drugs to the…
Read Article

A Decade Later, Patient Receiving CAR T-Cell Therapy “Cured of Cancer”

February 2022 has been an important month in…
Read Article